Abstract
This article discusses the complications of the disease in patients with a history of Covid-19. Severe severity according to the NIHSS scale was detected in 43.3% of patients with AT and 40.0% with CE, extreme severity was observed in 25.4% with AT and 36.4% with CE. Thus, severe IS at admission was detected in 36.6% of all examined patients and in 73.8% of patients with AT and CE subtypes of IS.
References
Akilov H. et al. Interim guidelines for the management of patients infected with COVID-19 (Version 10). Ministry of Health of the Republic of Uzbekistan and the National Chamber of Health of the Republic of Uzbekistan, January 2022.
Alferova, V. V. Clinical significance of humoral compensatory reactions in the acute period of ischemic stroke / V. V. Alferova, M. G. Uzbekov, E. Yu. Misionzhnik // Journal of Neurology and Psychiatry named after S. S. Korsakov. – 2011. – № 8. – P. 36–40.
Prognostic criteria for outcomes of hemorrhagic and ischemic strokes in the acute period: a guide for doctors / OA Balunov, N. Yu. Safonova. - St. Petersburg, 2010. – P. 19.
Wayne, A. M. Autonomic disorders. Clinic, diagnosis, treatment / A. M. Wein. – Moscow: Medical Information Agency, 2003. – P. 752.
Vilensky, B. S. Stroke - the current state of the problem / B. S. Vilensky // Neurological journal.– 2008. – № 2. – P. 4–10.
This work is licensed under a Creative Commons Attribution 4.0 International License.